Pfizer (PFE)

21.87 -0.17 -0.77% May 31, 5:20PM Go Pro

Watch this stock

Pfizer PS Value: 20.55

View PFE PS Value with YCharts Pro.

Access these YCharts Pro features:

Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience

and much more...

PFE PS Value Rankings

Overall	55th percentile	1509 of 3379
Sector	57th percentile	134 of 314 in Healthcare
Industry	9th percentile	10 of 11 in Drug Manufacturers - Major

PFE PS Value Range, Past 5 Years

Minimum	19.70	Dec 2011
Maximum	31.33	Sep 2007
Average	24.26

About PS Value (Pro)

Click the "Learn More" link below to see how YCharts calculates the PS Value.

The PS Method values stocks by applying a historical average of median Price to Sales Ratios to current trailing 12 months sales numbers. Investors should always check to ensure that they are comfortable with the estimated historical Price to Sales Ratio given information today before investing based on this valuation.

Many investors prefer to use sales numbers to value stocks since they are slightly more difficult than earnings to "edit" using accounting practices. This method tends to overvalue companies that have historically traded at very high PS ratios (usually growth firms), and tends to undervalue companies that historically traded at low PS ratios.

In order to help help investors avoid unreasonable valuations, we have set a maximum Price to Sales multiple of 10, even if the company historically has traded at higher values. If the intelligent investor has good reason to apply a higher multiple, they may choose to do so, but we will not publish numbers that high because they are rarely sustained.
Learn More

You may also be interested in these PFE related companies

Options

PFE News

ASCO 2012 Preview
May 31, 6:57PM Fool

Is it Time to Buy 2012's Worst Biotechs?
May 31, 4:40PM Fool

Goldman Makes "The Case for Breaking Up J&J"
May 31, 3:52PM

15 Great Stocks with Great Yield
May 31, 3:40PM Benzinga

Big Bets on MS
May 31, 3:29PM Fool

Drugmakers Vowed to Campaign for Health Law, Memos Show
May 31, 2:51PM

No Good News for Waiting Chelsea Investors
May 31, 1:50PM Fool

Republicans Attempt to Repeal Taxes for U.S. Health Law
May 31, 1:44PM

Vivus' Qnexa Is Not Guaranteed Approval. Remember Provenge?
May 31, 12:52PM Benzinga

$AMRN I would be surprised if $PFE isn't having backchannel talks pre-889.$AMRN is a perfect takeout...very few employees and cinch approval
about 7 hours ago by InTheBarn

Largest option buying in equities so far
May 31, 11:32AM

Is the NASDAQ on Sale?
May 31, 11:10AM

5 Defensive Plays for Long Term Investors
May 31, 11:00AM Investor Place

Drug Stocks In The Spotlight At ASCO Conference. $JNJ $CELG $ONXX $RHHBY $PFE http://stks.co/42e8
about 17 hours ago by abubnic

FTC picks legal sharpshooter for U.S. probe of Google
May 31, 1:02AM

6 Dividend Stocks In The Top 20 Of Hedge Fund Positions
May 31, 12:30AM

Pace of Rising Health Costs May Slow for U.S., Study Says
May 31, 12:01AM

Kaye Scholer, Hogan Lovells, Baker & McKenzie: Business of Law
May 31, 12:00AM

House Passes FDA’s $6.4 Billion Fee Plan for Drug Reviews
May 31, 12:00AM

@SciGuy $DRRX I don't believe so; the fortunes of DURECT are tied to $PFE and Remoxy
about 20 hours ago by SlownSteady

The Tale of 2 Patents
May 30, 10:36PM Fool

@SCarolinaguy $DRRX licensed the drug to $PTIE; $PTIE licensed it to King and $PFE bought King; I think people might forget about $DRRX
about 21 hours ago by SlownSteady

@SlownSteady Sounds encouraging with $PFE supporting. What is the relationship? Surely their support would lead to approval
about 21 hours ago by SCarolinaguy

@SCarolinaguy $DRRX $PFE plans to resubmit the NDA. The company has other products; a recent filed trial triggered share price punishment
about 21 hours ago by SlownSteady

@SCarolinaguy $DRRX Only insiders know. CMC problems are usually resolved. $PFE will have new data and meet with the FDA
about 21 hours ago by SlownSteady

Merck, Pfizer Back Lawmakers Who Oppose Company Products
May 30, 8:00PM

Veterans Affairs to open Mission Bay research center
May 30, 6:53PM

Antares Pharma is undervalued at this level by bad Grecce /Spain Market however $AIS , $PFE, $WPI , $ISIS , $ARNA , $AMRN
about a day ago by BioInvestor

The Drug Works, but Is It Worth Proceeding?
May 30, 3:21PM Fool

Keep a Close Eye on VIVUS
May 30, 3:00PM Fool

2 of 3 Best Performers in Dow are unchanged. $PFE, $T
about a day ago by frotuss

Dow Best Performers $WMT .12 $T .03 $PFE .01 Hey, that's awesome!
about a day ago by frotuss

Still a Bear Market http://stks.co/41w8 $KFT $MCD $MRK $MSFT $PFE $KO
about a day ago by LouisEbner

[video] Taking Stock of the Markets
May 30, 8:04AM

Facebook's Fall: Slide Carves $21B Off Market Cap In 7 Trading Days
May 29, 5:39PM

The Biggest U.S. IPOs Of The Last 25 Years
May 29, 5:39PM

What Moved Cisco and These 4 Heavily Traded Stocks?
May 29, 5:12PM

Cell Therapeutics' JAK2 Inhibitor Acquisition Is A Smart Pick-Up
May 29, 3:45PM

Mylan starts selling generic Lipitor in the US
May 29, 2:52PM

Dow Dividend Checkup: Johnson & Johnson
May 29, 2:30PM Fool

Drugs To Watch At ASCO 2012
May 29, 2:20PM

Midday Glance: Pharmaceuticals companies
May 29, 1:17PM

Does Pfizer Have Institutional Stock Support for its Future Product Pipeline?
May 29, 12:52PM

Who Should Buy Amylin?
May 29, 11:37AM Fool

Top 6 Stocks to Buy for June
May 29, 11:15AM Investor Place

Early Glance: Pharmaceuticals companies
May 29, 11:05AM

Teva Issues 2012 Outlook - Analyst Blog
May 29, 11:00AM Zacks

5 Healthcare Stocks With The Highest Cash
May 29, 7:32AM Benzinga

Koesterich Bullish On Dividend ETFs (HDV, DVYE, DVY)
May 28, 5:22AM Benzinga

RT @Glopolon: Does it matter, they are next door to $PFE $AMRN /i live next to a lawyer. odds of being sued increased day they moved in. Hmm
about 4 days ago by ITradeforMe

@troygrim @Bleedblue Does it matter, they are next door to $PFE $AMRN
about 4 days ago by Glopolon

RT @Glopolon $AMRN $PFE 'I wanna get close to you' Rose Royce http://stks.co/404L <Hmmmmmmmm!?$$$
about 4 days ago by Bleedblue

$AMRN $PFE 'I wanna get close to you' Rose Royce http://stks.co/404H
about 4 days ago by Glopolon

$AMRN dont have a dollar figure but Cafe Pharma had an interesting post on $PFE and $AMRN
about 4 days ago by StanD

@SomeGuy900 @christy155 $DRXX If $PFE gets a class 2 resubmission, they'll know in Q2/Q3 of next year; class one they'll know in Q1/Q2 '13
about 5 days ago by SlownSteady

@SomeGuy900 @christy155 $DRXX The $PFE discussions with the FDA should be in Q3; I imagine they will resubmit in early 2013
about 5 days ago by SlownSteady

$SPY $PFE wow - what a dead stock - surely there is good reason $$
about 5 days ago by WorldJazz59

@SomeGuy900 @christy155 The last comment from $DRRX management was that $PFE was getting ready to talk to the FDA about some more studies
about 5 days ago by SlownSteady

@SomeGuy900 @christy155 $DRRX I have no idea what's going on. It's gone up 20 cents since I bought in. Maybe $PFE will talk with the FDA
about 5 days ago by SlownSteady

Antares Pharma is undervalued at this level by bad Grecce market $AIS , $PFE, $WPI , $ISIS , $ARNA , $AMRN
about 5 days ago by BioInvestor

The Dow's 3 Biggest Losers This Week
May 26, 5:09PM Fool

Have J&J's Approval Hopes Vanished?
May 26, 8:09AM Fool

Best Dogs Of The Dow Jones As Of May 2012 + http://stks.co/3zos + $T $VZ $MRK $PFE $GE $JNJ $PG $DD $CVX $JPM
about 6 days ago by DividendYield

The Meaningless Drug Approval That Could Cost the Industry Billions
May 25, 4:36PM Fool

Amylin Shares Jump as Sanofi, Merck Sumbit Bids
May 25, 3:15PM Benzinga

Shareholder 'Smart Bombs' Shaking Up Proxy Meetings
May 25, 11:35AM Fox Business

Pfizer (PFE) Axitinib Gets Positive Opinion from CHMP EMA
May 25, 9:14AM Street Insider

Pfizer's Axitinib Receives Positive Opinion from the Committee for Human Medicinal Products for the Second-line Treatment of Advanced Kidney Cancer in the EU
May 25, 9:14AM Benzinga

Shorter Timeframe, More Risky
May 24, 3:11PM Fool

Bull Case for Mannkind
May 24, 2:00PM Fool

Is Bristol a Buy Post-Plavix
May 23, 5:38PM Fool

Buy, Sell, or Hold: Johnson & Johnson
May 23, 1:53PM Fool

Pfizer's Success Tied Closely to Pristiq
May 23, 12:20PM Fool

Pfizer (PFE) Promotes Olivier Brandicourt to GM of Emerging Markets, Established Products Units
May 23, 7:31AM Street Insider

3 Dow Stocks That Held the Average Down
May 22, 9:08PM Fool

Health Care SPDR In Focus Ahead Of Obamacare Decision
May 22, 12:34PM Benzinga

The Definitive Biotech ETF Guide (IBB, XBI, FBT)
May 21, 1:35PM Benzinga

Shorts Are Piling Into These Stocks. Should You Be Worried?
May 21, 10:45AM Fool

Why Johnson & Johnson is a Buy
May 21, 10:40AM Fool

Eaton Scoops up Cooper Industries for $11.8B
May 21, 10:00AM Fox Business

Bristol-Myers Squibb's Thud Heard Round the World
May 20, 4:07PM Fool

4 Picks From Cramer's Dividend Stocks: Part II
May 19, 6:16PM

Healthcare Business Recap: Dendreon Attack Continues, Pfizer Recall
May 18, 5:49PM

Microsoft and 3 Dow 30 Giants Making Moves
May 18, 1:51PM

Pfizer recalls Advil bottles from distributors
May 18, 1:32PM

Pfizer (PF) Updates on Effect of Lyrica on Pain in Fibromyalgia Patients
May 18, 8:02AM Street Insider

Recent Quotes

Symbol	Price	Chg	Chg %	Market Cap
PFE	21.87	-0.17	-0.77%	166.12B
PETM	64.47	+0.02	+0.03%	7.082B
PETD	24.80	+0.06	+0.22%	584.84M
PERY	18.82	-0.07	-0.37%	296.95M
PERI	3.86	-0.19	-4.69%	40.18M
PERF	7.80	-0.01	-0.13%	70.06M
PER	19.93	-0.07	-0.35%	787.60M
PEP	67.99	-0.23	-0.34%	108.30B
PEOP	16.08	+0.33	+2.10%
PEO	23.01	-0.18	-0.78%

Create Watchlist from Stock Quotes